• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    MDB Capital Holdings Provides First Quarter 2025 Update

    5/21/25 9:00:00 AM ET
    $BEAT
    $MDBH
    Medical/Dental Instruments
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $BEAT alert in real time by email

    Addison, TX, May 21, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, today provides an update on operations through and subsequent to the quarter ended March 31, 2025.

    First Quarter 2025 and Subsequent Operational Highlights

    • Closed a public offering of common stock for HeartBeam, Inc (NASDAQ:BEAT) with gross proceeds of approximately $11.5 million.
    • Completed LOIs for 3 new "Big Idea" companies to launch in 2025.
    • Increased our MDBH shareholder base by 4.5% during Q1 2025.
    • Onboarded 111 new MDB Direct accounts during the first quarter, a 26% increase since the end of 2024.
    • Broadened our relationships with angel groups, RIAs and family offices to expand awareness and participation in public venture financings.
    • Exploring innovative new approaches to leverage our self-clearing platform to broaden our IPO offerings for early-stage and emerging companies beyond deep tech.
    • Revised executive compensation plan for four top executives to realign compensation incentives with shareholder interests.

    "Despite the market volatility and cautious investor climate, we are seeing a steady flow of micro-cap companies with really exciting technologies that want to go public but have been unable to get the right partner to get them there. During first quarter, we have continued to work on a robust pipeline of new opportunities in the final stages of diligence which will enable us to focus on scaling the number of disruptive technology ideas we turn into valuable public companies this year," said Christopher Marlett, Co-Founder and CEO of MDB Capital Holdings.  

    First Quarter 2025 Update Zoom Webinar at 4:30 p.m. ET Today

    Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period.

    Investors can pre-register now for the Zoom webinar HERE. The live webinar can also be accessed on the day of the event through MDB's investor relations website at https://investors.mdb.com/.

    About MDB Capital Holdings, LLC

    Founded in 1997, MDB Capital focuses on launching "Big Ideas" into valuable public companies with a better approach to public venture capital. This approach involves community-driven financings of pre-revenue, early-stage disruptive technology companies through early public offerings, primarily listed on NASDAQ, as well as post-IPO offerings for already public companies that fit MDB's overall criteria for investment.

    MDB Capital is the brand under which MDB Capital Holdings, LLC (NASDAQ:MDBH) and its subsidiaries operate and provide services, which includes a self-clearing broker-dealer and trading platform and an integrated, intellectual property (IP) strategy consulting and law firm. MDB Capital is a registered broker-dealer, Member FINRA/SIPC.

    For more information, please visit www.mdb.com.

    Forward-Looking Statements

    This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.

    Investor Relations Contact:

    [email protected]

    Media Contact:

    [email protected]



    Primary Logo

    Get the next $BEAT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BEAT
    $MDBH

    CompanyDatePrice TargetRatingAnalyst
    Heartbeam Inc.
    $BEAT
    12/20/2021$9.00Speculative Buy
    Benchmark
    More analyst ratings

    $BEAT
    $MDBH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Benchmark initiated coverage on BioTelemetry with a new price target

      Benchmark initiated coverage of BioTelemetry with a rating of Speculative Buy and set a new price target of $9.00

      12/20/21 7:19:06 AM ET
      $BEAT
      Medical/Dental Instruments
      Health Care

    $BEAT
    $MDBH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Co-Founder Marlett Christopher A bought $442 worth of shares (100 units at $4.42) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      7/15/25 9:02:05 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • Co-Founder Marlett Christopher A bought $197 worth of shares (44 units at $4.48) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      6/26/25 5:00:51 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • Co-Founder Marlett Christopher A bought $6,457 worth of shares (1,565 units at $4.13) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      6/24/25 2:11:04 PM ET
      $MDBH
      Finance: Consumer Services
      Finance

    $BEAT
    $MDBH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Heartbeam Inc.

      SC 13D - HeartBeam, Inc. (0001779372) (Subject)

      10/25/23 4:01:55 PM ET
      $BEAT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D filed by Heartbeam Inc.

      SC 13D - HeartBeam, Inc. (0001779372) (Subject)

      8/28/23 4:26:34 PM ET
      $BEAT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D filed by Heartbeam Inc.

      SC 13D - HeartBeam, Inc. (0001779372) (Subject)

      6/2/23 2:36:13 PM ET
      $BEAT
      Medical/Dental Instruments
      Health Care

    $BEAT
    $MDBH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Co-Founder Marlett Christopher A bought $442 worth of shares (100 units at $4.42) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      7/15/25 9:02:05 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • Co-Founder Marlett Christopher A bought $197 worth of shares (44 units at $4.48) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      6/26/25 5:00:51 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • Co-Founder Marlett Christopher A bought $6,457 worth of shares (1,565 units at $4.13) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      6/24/25 2:11:04 PM ET
      $MDBH
      Finance: Consumer Services
      Finance

    $BEAT
    $MDBH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market

      DALLAS, TX , July 10, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP strategy and legal firm, today announced the release of The Next Era of Surgical Robotics, a new report that maps the most important shift in medtech since the rise of the da Vinci system. Built from analysis of more than 18,000 patent families, $4B in M&A activity, and deep dives into 28 robotic platforms, the report shows a sector no longer defined by a single system but by a race for platform defensibility. The findings challenge the assumption that surgical robotics is a saturated category. Despite more than 310 million surgeries performed globally each year, fewer than 6% involve robots. That num

      7/10/25 12:00:00 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

      HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that Robert Eno, Chief Executive Officer, and Timothy Cruickshank, Chief Financial Officer, will present at the iAccess Alpha Virtual Best Ideas Summer Conference on Tuesday, June 24, 2025. Eno and Cruickshank will also host virtual one-on-one meetings with institutional investors during the event. iAccess Alpha Virtual Summer Conference Dates: June 24-25, 2025 Location: Virtual Format: Presentation and Virtual 1x1 Meetings Attendees: Robert Eno, Chief Executive Officer, and Timothy Cruickshank, Chief Financial Officer Presentation T

      6/17/25 7:00:00 AM ET
      $BEAT
      Medical/Dental Instruments
      Health Care
    • MDB Capital Holdings Announces Transitions In Its Board of Directors

      Addison, TX, June 02, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, today announced key leadership transitions within its Board of Directors. Matthew Hayden, a board director since July 2022, will step down effective June 30, 2025, to assume a newly created role as Entrepreneur in Residence. In this position, Mr. Hayden will continue to support MDB's mission by applying his three decades of experience as an operator, investor, and strategic advisor to help guide early-stage disruptive technology companies through launch and growth while significantly expanding the

      6/2/25 5:20:00 PM ET
      $MDBH
      Finance: Consumer Services
      Finance

    $BEAT
    $MDBH
    SEC Filings

    See more
    • Heartbeam Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - HeartBeam, Inc. (0001779372) (Filer)

      7/16/25 2:15:18 PM ET
      $BEAT
      Medical/Dental Instruments
      Health Care
    • MDB Capital Holdings LLC filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - MDB Capital Holdings, LLC (0001934642) (Filer)

      6/2/25 5:05:19 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • SEC Form DEF 14A filed by Heartbeam Inc.

      DEF 14A - HeartBeam, Inc. (0001779372) (Filer)

      5/28/25 9:12:56 PM ET
      $BEAT
      Medical/Dental Instruments
      Health Care

    $BEAT
    $MDBH
    Leadership Updates

    Live Leadership Updates

    See more
    • HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

      Board expansion reflects Company's commitment to leadership and innovation in remote cardiac monitoring HeartBeam, Inc., (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced the appointment of Chief Executive Officer, Robert Eno, to its Board of Directors. As the Company continues to make significant advancements towards commercial readiness, the Board elected to expand from eight to nine members to accommodate this addition. Mr. Eno joined HeartBeam as President in January 2023 and was appointed CEO in October 2024. With over 30 years of experience in the medical technology industry, he has a proven

      5/5/25 7:00:00 AM ET
      $BEAT
      Medical/Dental Instruments
      Health Care
    • HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

      First cable-free, ambulatory ECG that captures the heart's electrical signals from three distinct directions for high-fidelity data collection and advanced diagnostics Patients can have the credit card-sized device with them at all times, ready to record an ECG whenever they feel symptoms and reduce delays in care Company to initiate Early Access Program to gain important patient and physician feedback on the use of the system in preparation for commercial launch HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that the US Food and Drug Administration (FDA) has granted 510(k) cl

      12/16/24 8:31:00 AM ET
      $BEAT
      Medical/Dental Instruments
      Health Care
    • HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

      Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and delivering growth Founder and current CEO Branislav Vajdic named President to focus on advancing the Company's groundbreaking vector-based technology for heart health, including AI applications HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful insights wherever the patient is, announced that Robert Eno has been appointed Chief Executive Officer (CEO), effective Monday, October 21, 2024. The seasoned MedTech executive joined HeartBeam as President in January 2023 and will lead as the Company continues to work

      10/17/24 8:31:00 AM ET
      $BEAT
      Medical/Dental Instruments
      Health Care

    $BEAT
    $MDBH
    Financials

    Live finance-specific insights

    See more
    • MDB Capital Holdings to Host First Quarter 2025 Results Conference Call on Wednesday May 21, 2025, at 4:30 p.m. Eastern Time

      Addison, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Wednesday May 21, 2025 at 4:30 p.m. Eastern Time to discuss its results for the first quarter 2025. A press release detailing these results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoom web

      5/14/25 8:55:00 AM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

      HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, will hold a conference call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2025, and will be providing updates on regulatory initiatives, commercial-readiness activities and anticipated milestones. A press release detailing these results will be issued prior to the call. HeartBeam CEO Robert Eno and CFO Timothy Cruickshank will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presentation, which can be viewed during the web

      5/1/25 8:31:00 AM ET
      $BEAT
      Medical/Dental Instruments
      Health Care
    • MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time

      Addison, TX, March 24, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Monday March 31, 2025 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2024. A press release detailing these results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoo

      3/24/25 8:50:00 AM ET
      $MDBH
      Finance: Consumer Services
      Finance